http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017133684-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2017-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a35fe0031c2e37070b169a6ea524784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65734588868608c755926c3aec6a7d53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bbd569bb3c16cbfb6919528b3d9d998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b168e38b88091a08a8ef06e5c5d8ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_861251e34bdfa8a7a7a5e571f8c3dd78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bfb87066a2ca4ff572861ae69df25ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d7a98ae9bdd14c39abf4b8a39da2843
publicationDate 2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017133684-A1
titleOfInvention Tlr7 agonist crystalline form a, preparation method and use thereof
abstract The present invention relates to crystalline form A of a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)-benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine (formula I), a method for preparing the crystalline form A, and the use thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022031057-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022031011-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973826-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021177679-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020216274-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10654856-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3412671-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10780091-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020162705-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022031021-A1
priorityDate 2016-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015168269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016023511-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104780924-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104780923-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312904107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118900043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467799079

Total number of triples: 40.